[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ibritumomab Tiuxetan Market Research Report 2016

December 2016 | 100 pages | ID: GDE86214B1AEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Ibritumomab Tiuxetan

Revenue, means the sales value of Ibritumomab Tiuxetan

This report studies Ibritumomab Tiuxetan in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Avid Radiopharmaceuticals
  • GE Healthcare
  • AREVA Med
  • Bayer HealthCare Pharmaceuticals
  • Cardinal Health
  • Immunomedics
  • Lantheus Medical Imaging
  • Merck
  • Navidea
  • Nordion
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Ibritumomab Tiuxetan in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Ibritumomab Tiuxetan in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Ibritumomab Tiuxetan Market Research Report 2016

1 IBRITUMOMAB TIUXETAN MARKET OVERVIEW

1.1 Product Overview and Scope of Ibritumomab Tiuxetan
1.2 Ibritumomab Tiuxetan Segment by Type
  1.2.1 Global Production Market Share of Ibritumomab Tiuxetan by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Ibritumomab Tiuxetan Segment by Application
  1.3.1 Ibritumomab Tiuxetan Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Ibritumomab Tiuxetan Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Ibritumomab Tiuxetan (2011-2021)

2 GLOBAL IBRITUMOMAB TIUXETAN MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ibritumomab Tiuxetan Production and Share by Manufacturers (2015 and 2016)
2.2 Global Ibritumomab Tiuxetan Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Ibritumomab Tiuxetan Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Ibritumomab Tiuxetan Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ibritumomab Tiuxetan Market Competitive Situation and Trends
  2.5.1 Ibritumomab Tiuxetan Market Concentration Rate
  2.5.2 Ibritumomab Tiuxetan Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IBRITUMOMAB TIUXETAN PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Ibritumomab Tiuxetan Production and Market Share by Region (2011-2016)
3.2 Global Ibritumomab Tiuxetan Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL IBRITUMOMAB TIUXETAN SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Ibritumomab Tiuxetan Consumption by Regions (2011-2016)
4.2 North America Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Ibritumomab Tiuxetan Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL IBRITUMOMAB TIUXETAN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Ibritumomab Tiuxetan Production and Market Share by Type (2011-2016)
5.2 Global Ibritumomab Tiuxetan Revenue and Market Share by Type (2011-2016)
5.3 Global Ibritumomab Tiuxetan Price by Type (2011-2016)
5.4 Global Ibritumomab Tiuxetan Production Growth by Type (2011-2016)

6 GLOBAL IBRITUMOMAB TIUXETAN MARKET ANALYSIS BY APPLICATION

6.1 Global Ibritumomab Tiuxetan Consumption and Market Share by Application (2011-2016)
6.2 Global Ibritumomab Tiuxetan Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IBRITUMOMAB TIUXETAN MANUFACTURERS PROFILES/ANALYSIS

7.1 Avid Radiopharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Avid Radiopharmaceuticals Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 GE Healthcare
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 GE Healthcare Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 AREVA Med
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 AREVA Med Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Bayer HealthCare Pharmaceuticals
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Bayer HealthCare Pharmaceuticals Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Cardinal Health
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Cardinal Health Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Immunomedics
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Immunomedics Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Lantheus Medical Imaging
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Lantheus Medical Imaging Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Merck
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Merck Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Navidea
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Navidea Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Nordion
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Ibritumomab Tiuxetan Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Nordion Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 IBRITUMOMAB TIUXETAN MANUFACTURING COST ANALYSIS

8.1 Ibritumomab Tiuxetan Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ibritumomab Tiuxetan

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ibritumomab Tiuxetan Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ibritumomab Tiuxetan Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IBRITUMOMAB TIUXETAN MARKET FORECAST (2016-2021)

12.1 Global Ibritumomab Tiuxetan Production, Revenue Forecast (2016-2021)
12.2 Global Ibritumomab Tiuxetan Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Ibritumomab Tiuxetan Production Forecast by Type (2016-2021)
12.4 Global Ibritumomab Tiuxetan Consumption Forecast by Application (2016-2021)
12.5 Ibritumomab Tiuxetan Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Ibritumomab Tiuxetan
Figure Global Production Market Share of Ibritumomab Tiuxetan by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Ibritumomab Tiuxetan Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Ibritumomab Tiuxetan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Ibritumomab Tiuxetan Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Ibritumomab Tiuxetan Production of Key Manufacturers (2015 and 2016)
Table Global Ibritumomab Tiuxetan Production Share by Manufacturers (2015 and 2016)
Figure 2015 Ibritumomab Tiuxetan Production Share by Manufacturers
Figure 2016 Ibritumomab Tiuxetan Production Share by Manufacturers
Table Global Ibritumomab Tiuxetan Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Ibritumomab Tiuxetan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Ibritumomab Tiuxetan Revenue Share by Manufacturers
Table 2016 Global Ibritumomab Tiuxetan Revenue Share by Manufacturers
Table Global Market Ibritumomab Tiuxetan Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Ibritumomab Tiuxetan Average Price of Key Manufacturers in 2015
Table Manufacturers Ibritumomab Tiuxetan Manufacturing Base Distribution and Sales Area
Table Manufacturers Ibritumomab Tiuxetan Product Type
Figure Ibritumomab Tiuxetan Market Share of Top 3 Manufacturers
Figure Ibritumomab Tiuxetan Market Share of Top 5 Manufacturers
Table Global Ibritumomab Tiuxetan Production by Regions (2011-2016)
Figure Global Ibritumomab Tiuxetan Production and Market Share by Regions (2011-2016)
Figure Global Ibritumomab Tiuxetan Production Market Share by Regions (2011-2016)
Figure 2015 Global Ibritumomab Tiuxetan Production Market Share by Regions
Table Global Ibritumomab Tiuxetan Revenue by Regions (2011-2016)
Table Global Ibritumomab Tiuxetan Revenue Market Share by Regions (2011-2016)
Table 2015 Global Ibritumomab Tiuxetan Revenue Market Share by Regions
Table Global Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table China Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table India Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Ibritumomab Tiuxetan Consumption Market by Regions (2011-2016)
Table Global Ibritumomab Tiuxetan Consumption Market Share by Regions (2011-2016)
Figure Global Ibritumomab Tiuxetan Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Ibritumomab Tiuxetan Consumption Market Share by Regions
Table North America Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table Europe Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table China Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table Japan Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table India Ibritumomab Tiuxetan Production, Consumption, Import & Export (2011-2016)
Table Global Ibritumomab Tiuxetan Production by Type (2011-2016)
Table Global Ibritumomab Tiuxetan Production Share by Type (2011-2016)
Figure Production Market Share of Ibritumomab Tiuxetan by Type (2011-2016)
Figure 2015 Production Market Share of Ibritumomab Tiuxetan by Type
Table Global Ibritumomab Tiuxetan Revenue by Type (2011-2016)
Table Global Ibritumomab Tiuxetan Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Ibritumomab Tiuxetan by Type (2011-2016)
Figure 2015 Revenue Market Share of Ibritumomab Tiuxetan by Type
Table Global Ibritumomab Tiuxetan Price by Type (2011-2016)
Figure Global Ibritumomab Tiuxetan Production Growth by Type (2011-2016)
Table Global Ibritumomab Tiuxetan Consumption by Application (2011-2016)
Table Global Ibritumomab Tiuxetan Consumption Market Share by Application (2011-2016)
Figure Global Ibritumomab Tiuxetan Consumption Market Share by Application in 2015
Table Global Ibritumomab Tiuxetan Consumption Growth Rate by Application (2011-2016)
Figure Global Ibritumomab Tiuxetan Consumption Growth Rate by Application (2011-2016)
Table Avid Radiopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Avid Radiopharmaceuticals Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Avid Radiopharmaceuticals Ibritumomab Tiuxetan Market Share (2011-2016)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare Ibritumomab Tiuxetan Market Share (2011-2016)
Table AREVA Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AREVA Med Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure AREVA Med Ibritumomab Tiuxetan Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals Ibritumomab Tiuxetan Market Share (2011-2016)
Table Cardinal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health Ibritumomab Tiuxetan Market Share (2011-2016)
Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics Ibritumomab Tiuxetan Market Share (2011-2016)
Table Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantheus Medical Imaging Ibritumomab Tiuxetan Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Ibritumomab Tiuxetan Market Share (2011-2016)
Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Navidea Ibritumomab Tiuxetan Market Share (2011-2016)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Ibritumomab Tiuxetan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Nordion Ibritumomab Tiuxetan Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ibritumomab Tiuxetan
Figure Manufacturing Process Analysis of Ibritumomab Tiuxetan
Figure Ibritumomab Tiuxetan Industrial Chain Analysis
Table Raw Materials Sources of Ibritumomab Tiuxetan Major Manufacturers in 2015
Table Major Buyers of Ibritumomab Tiuxetan
Table Distributors/Traders List
Figure Global Ibritumomab Tiuxetan Production and Growth Rate Forecast (2016-2021)
Figure Global Ibritumomab Tiuxetan Revenue and Growth Rate Forecast (2016-2021)
Table Global Ibritumomab Tiuxetan Production Forecast by Regions (2016-2021)
Table Global Ibritumomab Tiuxetan Consumption Forecast by Regions (2016-2021)
Table Global Ibritumomab Tiuxetan Production Forecast by Type (2016-2021)
Table Global Ibritumomab Tiuxetan Consumption Forecast by Application (2016-2021)


More Publications